FDA Approves Two Skin Cancer Treatments for GlaxoSmithKline

by Benzinga Staff
May 29, 2013 2:45 PM | 18 seconds read | Make a Comment

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

GlaxoSmithKline (NYSE: GSK) won approval for two drugs to treat advanced skin cancer that are accompanied by diagnostic tests to help target the treatments.The Food and Drug Administration approved Tafinlar and Mekinist for patients with melanoma, the most dangerous form of skin cancer, that has spread or can't be surgically removed, the agency said today in a statement.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsFDA

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.